Stockscreener 앱 받기
44.21
0.36%
0.16
시간 외 거래:
44.01
-0.20
-0.45%
전일 마감가:
$44.05
열려 있는:
$44.08
하루 거래량:
3.15M
Relative Volume:
0.78
시가총액:
$18.89B
수익:
$2.35B
순이익/손실:
$1.30B
주가수익비율:
25.28
EPS:
1.7487
순현금흐름:
$1.05B
1주 성능:
+2.89%
1개월 성능:
+10.06%
6개월 성능:
+17.64%
1년 성능:
+39.38%
1일 변동 폭
$43.63
$44.26
1주일 범위
$43.02
$44.92
52주 변동 폭
$29.66
$44.92
로열티 파마 Stock (RPRX) Company Profile
명칭
Royalty Pharma Plc
전화
(212) 883-0200
주소
110 EAST 59TH STREET, NEW YORK, NY
Compare RPRX vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RPRX
Royalty Pharma Plc
|
44.21 | 18.82B | 2.35B | 1.30B | 1.05B | 1.7487 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.48 | 119.47B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
754.91 | 82.49B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.16 | 51.25B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
322.98 | 42.28B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
353.43 | 38.60B | 4.98B | 69.60M | 525.67M | 0.5198 |
로열티 파마 Stock (RPRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-30 | 업그레이드 | UBS | Neutral → Buy |
| 2025-09-30 | 개시 | Goldman | Buy |
| 2025-05-16 | 개시 | Morgan Stanley | Overweight |
| 2024-06-03 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-06-14 | 재개 | UBS | Buy |
| 2022-05-13 | 개시 | Scotiabank | Sector Outperform |
| 2022-04-27 | 개시 | Goldman | Buy |
| 2022-04-14 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2022-04-06 | 재개 | Morgan Stanley | Overweight |
| 2021-10-29 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-07-30 | 개시 | Tigress Financial | Buy |
| 2020-11-09 | 업그레이드 | UBS | Neutral → Buy |
| 2020-07-14 | 개시 | Evercore ISI | In-line |
| 2020-07-13 | 개시 | BofA Securities | Buy |
| 2020-07-13 | 개시 | Citigroup | Neutral |
| 2020-07-13 | 개시 | Cowen | Outperform |
| 2020-07-13 | 개시 | Goldman | Neutral |
| 2020-07-13 | 개시 | JP Morgan | Neutral |
| 2020-07-13 | 개시 | Morgan Stanley | Equal-Weight |
| 2020-07-13 | 개시 | SunTrust | Buy |
| 2020-07-13 | 개시 | UBS | Neutral |
모두보기
로열티 파마 주식(RPRX)의 최신 뉴스
Royalty Pharma earnings in focus after $4.7B deal spree - Investing.com
Royalty Pharma's Earnings: A Preview - Benzinga
Exploring Analyst Estimates for Royalty Pharma (RPRX) Q4 Earnings, Beyond Revenue and EPS - Yahoo Finance Australia
UBS and Citi Are Bullish on Royalty Pharma Plc (RPRX) – Here’s Why - Insider Monkey
Allianz Asset Management GmbH Sells 127,319 Shares of Royalty Pharma PLC $RPRX - MarketBeat
What To Expect From Royalty Pharma's (RPRX) Q4 Earnings - Finviz
What To Expect From Royalty Pharma’s (RPRX) Q4 Earnings - Yahoo Finance UK
Alps Advisors Inc. Acquires New Shares in Royalty Pharma PLC $RPRX - MarketBeat
Shorts Report: Will Royalty Pharma plc benefit from rate cutsJuly 2025 Outlook & Stock Timing and Entry Methods - baoquankhu1.vn
Rally Mode: Should I add Phoenix Laser Systems Inc Preferred Security stock to my portfolio2025 Market Sentiment & Weekly High Momentum Picks - baoquankhu1.vn
Thrivent Financial for Lutherans Trims Stake in Royalty Pharma PLC $RPRX - MarketBeat
The Best Biotech Stocks to Buy - morningstar.com
Ultragenyx (RARE) May Report Negative Earnings: Know the Trend Ahead of Q4 Release - Finviz
Royalty Pharma PLC (NASDAQ:RPRX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Royalty Pharma (NASDAQ:RPRX) Reaches New 1-Year HighHere's What Happened - MarketBeat
Royalty Pharma EVP Coyne sells $10.3 million in shares By Investing.com - Investing.com UK
C WorldWide Group Holding A S Raises Holdings in Royalty Pharma PLC $RPRX - MarketBeat
Homestead Advisers Corp Sells 37,000 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma EVP Coyne sells $10.3 million in shares - Investing.com
3 Mid-Cap Stocks We Keep Off Our Radar - Finviz
(RPRX) Risk Channels and Responsive Allocation - Stock Traders Daily
Royalty Pharma Set for Upcoming Dividend Payment - intellectia.ai
Royalty Pharma (NASDAQ:RPRX) CFO Sells $4,924,629.36 in Stock - MarketBeat
Terrance Coyne Sells 108,424 Shares of Royalty Pharma (NASDAQ:RPRX) Stock - MarketBeat
Terrance Coyne Sells 20,163 Shares of Royalty Pharma (NASDAQ:RPRX) Stock - MarketBeat
Royalty Pharma (RPRX) Earnings Expected to Grow: Should You Buy? - Finviz
AE Wealth Management LLC Lowers Holdings in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma (RPRX) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
Urist Marshall, royalty pharma EVP, sells $821,810 in shares By Investing.com - Investing.com South Africa
Urist Marshall, royalty pharma EVP, sells $821,810 in shares - Investing.com
Royalty Pharma (RPRX) Stock Analysis: Analysts See 15% Upside Potential - DirectorsTalk Interviews
Marshall Urist Sells 20,000 Shares of Royalty Pharma (NASDAQ:RPRX) Stock - MarketBeat
Mirae Asset Global Investments Co. Ltd. Buys 31,045 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Strs Ohio Lowers Stock Holdings in Royalty Pharma PLC $RPRX - MarketBeat
Is Royalty Pharma (RPRX) Still Attractive After A 35% One Year Share Price Gain - Yahoo Finance
Royalty Pharma stock hits 52-week high at $41.71 By Investing.com - Investing.com India
Royalty Pharma (NASDAQ:RPRX) Hits New 1-Year HighShould You Buy? - MarketBeat
Royalty Pharma stock hits 52-week high at $41.71 - Investing.com
Royalty Pharma Shares Rise After UBS Upgrade - marketscreener.com
UBS Upgrades Royalty Pharma to Buy From Neutral, Adjusts Price Target to $49 From $38 - marketscreener.com
Ruffer LLP Decreases Holdings in Royalty Pharma PLC $RPRX - MarketBeat
Assessing Royalty Pharma (RPRX) Valuation After Teva Autoimmune Funding Partnership Attracts Fresh Attention - Sahm
Royalty Pharma (NASDAQ:RPRX) EVP Marshall Urist Sells 20,000 Shares of Stock - MarketBeat
Royalty Pharma PLC $RPRX Shares Sold by Y Intercept Hong Kong Ltd - MarketBeat
Royalty Pharma to buy royalty interest in Amgen’s Imdelltra for up to $950M - MSN
Mitsubishi UFJ Trust & Banking Corp Sells 198,889 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Cullen Frost Bankers Inc. Raises Position in Royalty Pharma PLC $RPRX - MarketBeat
(RPRX) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Jim Cramer on Royalty Pharma: "It's a Terrific Company" - Finviz
84,741 Shares in Royalty Pharma PLC $RPRX Bought by Oxbow Advisors LLC - MarketBeat
Jim Cramer on Royalty Pharma: “It’s a Terrific Company” - Insider Monkey
로열티 파마 (RPRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
로열티 파마 주식 (RPRX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Coyne Terrance P. | EVP & CFO |
Feb 02 '26 |
Sale |
42.08 |
108,424 |
4,562,905 |
30,167 |
| Coyne Terrance P. | EVP & CFO |
Feb 04 '26 |
Sale |
43.29 |
20,163 |
872,913 |
22,885 |
1.16%
1.31%
자본화:
|
볼륨(24시간):